FDA Approves the First Non-Opioid Pain Drug in 20 Years - TIME

1 day ago · On Jan. 30, the U.S. Food and Drug Administration (FDA) approved a new drug called suzetrigine to treat moderate-to-severe pain. The prescription pills, sold under the brand name Journavx and made ...

CouponFollow Extension

$15.50
OFF

FDA Approves Journavx Drug To Treat Pain Without Addiction Risk

3 weeks from now

1 day ago · The Food and Drug Administration approved a new medication Thursday to treat pain from an injury or surgery. It is expensive, with a list price of $15.50 per pill. But unlike opioid …

nytimes.com

$7
OFF

FDA Approves Vertex’s Journavx As First New Pain Drug In Decades

3 weeks from now

1 day ago · A week after Purdue Pharma and the Sackler family agreed to pay $7.4 billion to settle lawsuits stemming from the company’s opioid-based painkiller OxyContin, the FDA …

biospace.com

FAQs about FDA Approves the First Non-Opioid Pain Drug in 20 Years - TIME Coupon?

Can a new non-opioid pain medication help treat acute pain?

To treat acute pain, doctors in the U.S. commonly prescribe opioids: powerful painkillers with dangerous side effects including serious risk of addiction and overdose. Now, the U.S. Food and Drug Administration (FDA) has green-lighted a promising alternative: a new non-opioid pain medication. ...

Is journavx an alternative to opioids?

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx. ...

Could a non-opioid pain medication be a safer alternative to naloxone?

Florida has taken steps to combat the opioid crisis, including stricter prescription regulations and expanded access to naloxone, a life-saving overdose reversal drug, according to the Florida Department of Health. The approval of Journavx, a non-opioid pain medication, could provide a safer alternative for pain management. ...

Can a new class of medication help relieve pain?

For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage certain kinds of pain. ...

Is FDA approval a public health milestone in acute pain management?

“Today’s approval is an important public health milestone in acute pain management,” Jacqueline Corrigan-Curay, acting director of the FDA’s Center for Drug Evaluation and Research, said in a statement. ...

How many people develop opioid use disorder a year?

Almost 10% of patients with acute pain who are treated initially with an opioid will go on to have prolonged opioid use, and roughly 85,000 people will develop opioid use disorder annually, Vertex said in a statement. ...